All publications
Everything we have to offer
Explore our latest thinking on the governance of emerging technologies.
Everything we have to offer
RAISE is Europe’s moonshot to lead in AI: bold, sovereign, and built for trust.
A targeted EU biosecurity strategy focused on early detection and fast response to future biological threats.
Consumer neurotechnology has rapidly expanded beyond medicine into everyday life, prompting CFG’s global analysis of 271 companies to better understand this fast-moving, underexamined sector.
Mirror life research explores building synthetic life with flipped molecular structures. Faouzi Braza argues that the EU must take this frontier seriously now, before mirror organisms become real and risks spiral beyond our ability to contain them.
AI is a fairly novel technology – and it presents policymakers with some particularly tricky questions. This series explores some of these challenges in in detail.
Enforcement is a crucial and often overlooked aspect of technology governance. Learn more about recent developments in the European tech enforcement space, and what the EU can do to improve oversight and implementation.
This series examines how biotechnology misuse could contribute to future pandemics, exploring emerging risks, biosecurity challenges, and Europe’s preparedness against evolving threats.